Parameter | Â | Silicone Oil Group | Gas (SF6 or C3F8) Group |
---|---|---|---|
Patients %(n) | Â | 44.8% (26) | 55.1% (32) |
Age (years) |  | 48.5±11.2 (23.0 to 69.0) | 48.6±13.9 (21.0 to 71.0) |
Gender % (n) | |||
 | Male | 66.7% (18) | 65.6% (21) |
 | Female | 33.3% (8) | 34.4% (11) |
Systemic disease % (n) | |||
 | HTN DM Dyslipidemia Depression | 11.5% (3) 7.6 %(2) 11.5% (3) 1.7 %(1) | 12.5% (4) 12.5% (4) 3.1% (1) 0% (0) |
RD quadrant % (n) | |||
 | Superior | 0% (0) | 3.1% (1) |
 | Nasal | 7.7% (2) | 3.1% (1) |
 | inferior | 19.2% (5) | 0% (0) |
 | Temporal | 3.8% (1) | 21.9% (7) |
 | Superonasal | 11.5% (3) | 9.4% (3) |
 | Inferonasal | 3.8% (1) | 3.1% (1) |
 | Inferotemporal | 34.6% (9) | 12.5% (4) |
 | Superotemporal | 19.2% (5) | 46.9% (15) |
Preoperative lens status | |||
 | Phakic | 53.8% (14) | 71.9% (23) |
 | Pseudophakic | 42.3% (11) | 25.0% (8) |
 | Aphakic | 3.8% (1) | 3.1% (1) |
Postoperative lens status | Â | Â | Â |
 | Phakic | 3.8% (1) | 18.8% (6) |
 | Pseudophakic | 92.3% (24) | 78.1% (25) |
 | Aphakic | 3.8% (1) | 3.1% (1) |
Postoperative follow up (months) | |||
 | Mean±SD | 9.3±7.0 | 11.6±11.0 |
 | Median (Range) | 6.5 (6.0 to 26.0) | 7.5 (5.0 to 40.0) |
Preoperative Central macular thickness (µm) | Mean±SD | 288±62 | 277±25 |
Tamponade indication | |||
 | Inferior break 46.1% (12) | Superior temporal break 46.9% (15) | |
 | Multiple break 38.4% (10) | Superior nasal break 34.3% (11) | |
 | Giant retinal break 7.7% (2) | Temporal break 12.5% (4) | |
 | Air travel 7.7% (2) | Nasal break 6.2.%. (2) | |
Silicone oil tamponade duration (months) | Â | Â | Â |
 | Mean±SD | 8.1±3.4 |  |
 | Median (Range) | 7.5 (4.0 to 18.0) |  |